Shalby Limited submitted a regulatory disclosure to the National Stock Exchange of India Ltd and BSE Limited regarding a management change at its wholly-owned subsidiary, Shalby Medtech Limited.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mr. Deepak Anand, Chief Executive Officer of Shalby Medtech Limited, resigned from his position via letter dated August 18, 2026. His resignation is effective from the close of business hours on September 4, 2026.
The stated reason for resignation is that Mr. Anand is moving abroad for personal reasons. The company specifically confirmed that there are no other material reasons for his resignation beyond those mentioned in his resignation letter.
The required details under Regulation 30 read with Part A of Schedule III of Listing Regulations were provided:
- Reason for change: Resignation as CEO of Shalby Medtech Limited to move abroad for personal reasons
- Date of cessation: Effective from close of business hours on September 4, 2026
- Brief profile: Not applicable
- Disclosure of relationship between directors: Not applicable
The disclosure was signed by Tushar Shah, AVP & Company Secretary (Mem. No. FCS-7216) of Shalby Limited on August 18, 2026, at 14:30:46 IST.
The resignation letter from Deepak Anand addressed to the Managing Director of Shalby MedTech Limited was attached to the filing. In his letter, Mr. Anand reiterated that moving abroad for personal reasons was the sole reason for his resignation and confirmed there were no other material reasons. He expressed gratitude to the Managing Director, Board, and leadership team of the Shalby Group for their support and stated he would ensure a smooth handover of responsibilities during the remaining period.